Q2 2025 Maravai LifeSciences Holdings Inc Earnings Call Transcript

Aug 11, 2025 / 09:00PM GMT

Release Date Price: $2.06 (-6.36%)

Transcript 10-Q8-K

Key Points

Positve

Maravai LifeSciences Holdings Inc (MRVI) has initiated a restructuring plan to reduce operating costs by more than $50 million annually, aiming for completion within the next 12 months.
The company is focusing on strategic levers for long-term value creation, including revenue diversification and growth across its businesses.
The Biologic Safety Testing (BST) segment showed strong year-over-year growth, with a 10% increase in revenue driven by demand for host cell protein kits and quantification services.
Maravai LifeSciences Holdings Inc (MRVI) is investing in e-commerce infrastructure and AI capabilities to enhance the commercial experience for research customers.
The company has a clear plan to return to sustainable, positive adjusted EBITDA and free cash flow by the second half of 2026.

Negative

Revenue for the second quarter of 2025 was $47.4 million, a significant decrease from $69.4 million in Q2 2024.
The company reported a GAAP net loss of $69.8 million for the second quarter of 2025, compared to a loss of $18.4 million in the same period of 2024.
Adjusted EBITDA was negative $10.4 million for Q2 2025, down from a positive $13 million in Q2 2024.
The Nucleic Acid Production (NAP) segment faced challenges with adjusted EBITDA at negative $7.3 million in Q2 2025.
Maravai LifeSciences Holdings Inc (MRVI) has withdrawn its prior guidance range for 2025 due to ongoing comprehensive business reviews and uncertainties.

Operator

Good afternoon everyone, and welcome to the Maravai Life Sciences second-quarter 2025 earnings results conference call. (Operator Instructions) Also, today's call is being recorded. (Operator Instructions)

Now, at this time, I'd like to turn things over to Deb Hart, Senior Director, Investor Relations. Please go ahead, ma'am.

Debra Hart

Maravai LifeSciences Holdings Inc - Senior Director, Investor Relations

Good afternoon, everyone. Thanks for joining us on our second-quarter 2025 earnings call. The press release and slides accompanied today's call are posted on our website and available at investors.maravai.com.

During today's call, management will make forward-looking statements and refer to GAAP and non-GAAP financial measures. It is possible that actual results could differ from management's expectations. We refer you to slide 3 for more detail on forward-looking statements and our use of non-GAAP financial measures.

The press release provides reconciliations to the most directly comparable GAAP measures, and we also post

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.